Patent Assignment
Reel/Frame 056601/0561
Change of Name
Recorded: 2021-06-16
Pages: 7
Assignor
SHIRE VIROPHARMA INCORPORATED
Executed: 2019-12-20
Assignee
SHIRE VIROPHARMA LLC
300 SHIRE WAY, LEXINGTON, MASSACHUSETTS, 02421
Covered Property
(1)
Methods of Treating Antibody-Mediated Rejection in Organ Transplant Patients with C1-Esterase Inhibitor
Application:
16/983,998 →
Publication:
US 2020/0360495
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 20, 2021
From: SHIRE VIROPHARMA LLC
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 056307/0254 →
Assignment of Assignor's Interest
Jun 16, 2021
From: BROOM, COLIN; UKNIS, MARK E.
To: VIROPHARMA HOLDINGS LIMITED
Reel/Frame 056562/0494 →
Assignment of Assignor's Interest
Jun 16, 2021
From: UKNIS, MARC E.
To: VIROPHARMA HOLDINGS LIMITED
Reel/Frame 056562/0532 →
Assignment of Assignor's Interest
Jun 16, 2021
From: VIRPHARMA HOLDINGS LIMITED
To: SHIRE VIROPHARMA INCORPORATED
Reel/Frame 056562/0636 →
Corrective Assignment to Correct the Assignor's Name Previously Recorded at Reel: 056562 Frame: 0636. Assignor(S) Hereby Confirms the Assignment .
Jun 28, 2021
From: VIROPHARMA HOLDINGS LIMITED
To: SHIRE VIROPHARMA INCORPORATED
Reel/Frame 056696/0043 →